The Mires of Research Evaluation

All organizations who fund and conduct scientific research are increasingly "under the gun" to better evaluate the performance of their programs. Scientific research is supported by two major sponsors; the federal government funds most basic research and industry supports the more applied research. These sponsors have organizational goals and obligations to their stakeholders. They must account for their expenditures and must justify these investment decisions. How to do so in a viable yet accep

| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

The key issue in research evaluation is the combination of the scientific process being such a complex phenomenon, and our constant desire to quantify its outcomes. This has led to the use of multiple indicators, such as counts of publications, counts of citations, and peer-review. The vast majority of the problems discussed by Phelan, Perry, and other writers are primarily due to the issues inherent in measuring complex phenomena with an array of indicators. Products from research include a wide variety of outcomes, from "nuggets" of knowledge to an array of ideas, concepts, methods, techniques, and explanations. Downstream outcomes include patents, prototypes, and design criteria. Certain metrics (such as bibliometrics) can only capture a portion of these outcomes. Moreover, these outcomes (or products) are differentially prioritized by performers and sponsors and create inherent conflicts.

Given that only a fraction of research is documented and captured by bibliometric measures, some, if ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eliezer Geisler

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours